FDA product code QDJ: Direct-To-Consumer Access Pharmacogenetic Assessment System

QDJ is the FDA product code for direct-to-consumer access pharmacogenetic assessment system. It is a Class II device, regulated under 21 CFR 862.3364 and reviewed by the Clinical Chemistry panel. FDA has cleared 2 510(k) submissions under QDJ, 1 in the last five years. The average 510(k) review took 182 days (median 182). 1 De Novo request was granted under it.

Definition

A direct-to-consumer access pharmacogenetic assessment system is a qualitative in vitro molecular diagnostic system used for detecting variants in nucleic acids isolated from human specimens the purpose of identifying pharmacogenetic associations for the detected variants. This device is for in vitro diagnostic use only, and is intended for direct access testing by lay users.

Classification

FieldValue
Device nameDirect-To-Consumer Access Pharmacogenetic Assessment System
Device classClass II
Regulation21 CFR 862.3364
Review panelCH — Clinical Chemistry
Medical specialtyMedical Genetics
Premarket route510(k)

510(k) clearances per year for QDJ

YearClearancesAvg. review days
20201244
20221119

Compare with all 510(k) review times · Search every QDJ clearance

Top QDJ applicants

ApplicantClearancesLatest
23AndMe, Inc.22022-10-26

Most recent QDJ clearances

510(k)ApplicantDeviceDecision dateReview days
K22188523AndMe, Inc.23andMe Personal Genome Service (PGS) Pharmacogenetic Reports2022-10-26119
K19349223AndMe, Inc.23andMe Personal Genome Service (PGS) Pharmacogenetic Reports2020-08-17244

Recalls for QDJ devices

openFDA lists no recalls for product code QDJ.

Frequently asked questions

What is FDA product code QDJ?

QDJ is the FDA product code for direct-to-consumer access pharmacogenetic assessment system. It is a Class II device, regulated under 21 CFR 862.3364 and reviewed by the Clinical Chemistry panel.

What device class is QDJ?

Class II, regulation 21 CFR 862.3364. Typical premarket route: 510(k).

How long does a 510(k) take for product code QDJ?

Across 2 cleared submissions the average was 182 days from receipt to decision (median 182).

Which companies have the most QDJ clearances?

23AndMe, Inc. (2).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times